Prostacyclin (PGI2) is a key mediator of pulmonary vasomotor tone during late gestation and in the newborn, and its production in whole lung increases during that period. We investigated the developmental regulation of PGI2 synthesis in ovine intrapulmonary artery (PA) segments from 110 to 115 d (Fl) and 125 to 135 d gestation fetal lambs (F2, term = 144 d) and 1-and 4-wk-old newborn lambs (NB1 and NB2). Basal PGI2 rose fourfold from F1 to F2, fourfold from F2 to NB1, and twofold from NB1 to NB2. In all age groups 66-72% of PGI2 was derived from the endothelium. Similar fold increases in PGI2 were observed with maturation in intact and endothelium-denuded segments. In intact PA from F2, NB1, and NB2, basal PGI2 synthesis and synthesis maximally stimulated by bradykinin, A23187, or arachidonic acid rose with development in a comparable manner. In contrast, PGI2 synthesis stimulated by exogenous PGH2, the product of cyclooxygenase, was similar at all ages. Immunoblot analyses of PA from F2, NB1, and NB2 revealed that there is a sixfold maturational increase in cyclooxygenase-1 protein; the cyclooxygenase-2 isoform was not detectable. Cyclooxygenase-1 mRNA abundance in whole lung also rose with development. Thus, PGI2 synthesis in ovine PA endothelium and vascular smooth muscle increases markedly during late fetal and early newborn life; the increase is due to a rise in cyclooxygenase activity related to enhanced expression of cyclooxygenase-1. We conclude that there is developmental regulation of PA cyclooxygenase-1 gene expression, and that this may be critical to successful cardiopulmonary transition and function in the newborn. (J. Clin. Invest. 1994.93:2230-2235 
istration of PGI2 causes pulmonary vasodilatation in the fetus and newborn, and vasoconstriction occurs when its endogenous synthesis is inhibited (1) (2) (3) (4) . In addition, PGI2 plays a major role in successful cardiopulmonary transition at the time of birth (5, 6) , and it attenuates hypoxic pulmonary vasoconstriction in the neonatal period (7) . There is evidence that PGI2 also modulates vascular cell growth in the pulmonary circulation (8-1 1). Pulmonary PGI2 is primarily synthesized in the endothelium and vascular smooth muscle (VSM) ( 12).
Studies in a variety of species indicate that the synthesis of PGT2 and other vasodilatory prostaglandins in whole lung increases dramatically during late gestation and in the newborn (13) (14) (15) . This increase may play an important role in the fall in pulmonary vascular resistance that occurs not only at birth, but also more gradually thereafter, and it may also be involved in maturational changes in pulmonary vessel structure ( 16) . The specific cell source of this developmental increase and the mechanism(s) underlying it are unknown.
The purpose of the present study was to determine the ontogeny ofPG12 synthesis in ovine intrapulmonary arteries (PA) during the late fetal and early newborn period, and to delineate the mechanism(s) underlying the developmental regulation of its synthesis. Based on the findings ofprevious investigations in whole lung (13) (14) (15) , we hypothesized that PGI2 synthesis in the PA increases in late gestation and the early postnatal period. In addition to testing this hypothesis, studies were performed to address the following questions: (a) Is the developmental increase in PGI2 synthesis specific to that prostanoid? (b) Is it specific to the PA? (c) Does the developmental increase in PGI2 synthesis occur in pulmonary artery endothelium or VSM? and (d) At what step in the PGI2 synthetic pathway is the developmental increase mediated?
Methods
Animal model. The lamb has been used extensively in investigations of the role of vasodilatory prostaglandins in the regulation of pulmonary vasomotor tone in the fetus and newborn ( 1-5, 12, 13, 17) . As such, it is an excellent animal model for the in vitro study of the ontogeny of PA PG12 synthesis. In the present investigation, PA segments were obtained from four groups ofmixed breed lambs. They were fetal lambs at 110-115 d gestation (Fl, n = 4); fetal lambs at 125-135 d gestation (F2, n = 21 ), with term being 144±4 d; newborn lambs 1-2 wk of age (NB1, n = 12); and newborn lambs 4 wk of age (NB2, n = 15). The pregnant ewes used (n = 35) were multiparous and had singletons (n = 22), twins (n = 9), or triplets (n = 4). Before killing, the animals were housed in the Animal Resources Center ofthe University ofTexas Southwestern Medical Center and were given standard animal chow and water ad lib. The procedures followed in the care and euthanasia of the study animals were approved by the Institutional Review Board for Animal Research.
Arterial segment preparation. The procedures used generally follow those we have previously reported ( 18) . Briefly, the ewe and fetus(es)
The newborn lambs were killed in a similar manner. The lungs were immediately removed and placed in ice-cold phosphate-buffered saline (0.01 M P04, 0.15 M NaCl, pH 7.4). Further tissue preparation was performed in a cold room at 40C. The intrapulmonary arterial tree was rapidly dissected from the lung parenchyma and placed in fresh icecold phosphate-buffered saline. Remaining fatty and connective tissue was removed and the adventitia was grossly dissected from the arteries, taking care not to disrupt the endothelium. Fourth generation PA were isolated and placed in freshly prepared Krebs-Henseleit buffer gassed with 95% 02/ 5% CO2 at 370C ( 1 9). The Krebs-Henseleit buffer contained the following (mM): 4.8 KCl, 2.0 CaC12, 1.2 KH2PO4, 1.2 MgSO4, 11.0 dextrose, 118 NaCl, and 25 NaHCO3 at pH 7.4 . Fourth generation arteries were chosen for study in an effort to examine these biochemical mechanisms in freshly obtained intact arterial segments as close to the level of the resistance vessels as possible ( 19) . Segments with wet weights of 1-4 mg were cut, rinsed in fresh oxygenated Krebs-Henseleit buffer, and equilibrated in the oxygenated buffer at 370C for 2 h. In some studies the endothelium was removed by repeated passage of silk suture through the artery lumen. The presence or absence of intact, functional endothelium was confirmed in randomly chosen segments by light microscopy of 5-gm sections of the arteries, examinations of endothelium-dependent relaxation with acetylcholine, and quantification of cGMP production with acetylcholine stimulation (20) . In selected animals, comparably sized mesenteric arteries were also obtained for use in parallel studies.
Third generation PA were also obtained from some animals for use in immunoblot analyses ( 19) . These arteries were chosen to provide sufficient tissue for evaluations of protein abundance in microsomal preparations (see below). Whole lung was also harvested to obtain adequate quantities of poly(A)+ RNA for Northern analyses (see below). At the time of killing, the third generation arteries and the lung specimens were rapidly dissected and frozen immediately in liquid nitrogen.
Incubations for prostaglandin synthesis. The incubation procedures used were similar to those we have used in previous studies of arteries from fetal and newborn lambs ( 18, 21, 22) . The segments were placed individually into sealed polypropylene chambers containing 2.0 ml of oxygenated (P02 = 680 mmHg) Krebs-Henseleit buffer at 37°C for 1 h. After this preincubation period, the media was replaced with fresh oxygenated Krebs-Henseleit buffer and a 15-120-min incubation was performed at 37°C. At the end of the incubation, the media was placed into ice-cold tubes containing 100 gg of acetylsalicylic acid and was stored at -20°C until the time of assay for PGI2 or PGE2 by radioimmunoassay. The segments were placed in ice-cold 7% trichloroacetic acid and were stored at -20°C until protein content was determined by a modification of the method of Lowry et al. (23) , using bovine serum albumin as the standard. We have demonstrated that under these conditions the prostanoids measured are newly synthesized, and synthesis is linear with time for at least 120 min (21 ) .
Stimulated prostacyclin synthesis. In experiments designed to determine the reaction in the synthetic cascade that is involved in the developmental regulation of PGI2 synthesis, selected arterial segments were incubated in Krebs-Henseleit buffer alone, indicative of basal (nonstimulated) synthesis, and others were treated with agents that activate the synthetic pathway at various steps. We have previously used this approach to investigate oxygen modulation of PA PGI2 synthesis ( 18) . Incubations were performed in the presence of bradykinin to assess the effects of development on PGI2 synthesis stimulated by receptor-mediated mobilization of arachidonic acid from phospholipids (24) . Incubations with the calcium ionophore A23187 were done to determine the effects of maturation on PGI2 synthesis stimulated by an increase in cytosolic-free calcium, which activates arachidonic acid mobilization by a nonreceptor-mediated process (25) . Exogenous arachidonic acid was also used to stimulate PGI2 synthesis to reveal if the effect of development is reversed by provision of the precursor in excess (25) . Reversal ofthe maturational effect would be seen if the effect occurs proximal to arachidonic acid in the synthetic cascade, and a lack ofreversal would indicate that the mechanism involves changes in cyclooxygenase (COX) and/or PGI2 synthetase activity (25) . Lastly, incubations were performed in the presence ofPGH2, the product of COX activity and the substrate for PGI2 synthetase, to differentiate between potential developmental effects on the activities of these enzymes (25) . Studies of concentration-related responses and time courses of activation of the synthetic cascade were performed preliminarily in PA from F2 lambs. Maximal stimulation was found with bradykinin and A23 187 at 10-6 M, and with arachidonic acid and PGH2 at 10-' M. As a result, these concentrations were used in the experiments performed in the different age groups. Basal and stimulated prostaglandin production were linear with time for 2 15 min; ensuing incubations were 15 min in duration. In all experiments, duplicate segments were studied from four to six animals.
Prostaglandin radioimmunoassays. Samples of incubation media were assayed for the stable metabolite of PGI2, 6-keto-PGFia, and for PGE2 by radioimmunoassay as previously reported ( 18) . Briefly, the assay procedure used duplicate aliquots of standard (0-200 pg) and samples put into a mixture of Krebs-Henseleit solution and 0.1 M phosphate-buffered saline with 0.1% polyvinyl-pyrrolidone ( 1 :1 ). Antiserum (0.1 mL, 1:4,000 titer for 6-keto-PGFa and 1:14,000 titer for PGE2) and 0.1 mL of [3H ] -6-keto-PGF,. ( 12,000 cpm) or [3H] -PGE2 (16,500 cpm) were added and the tubes were incubated at 4°C for 12-18 h. The antisera were the kind gift of Dr. William B. Campbell (Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI). Bound and free ligand were counted by liquid scintillation spectrometry, and the unknown quantities ofprostaglandin were determined from the standard curves generated.
Immunoblot analysis for COX protein. Isolation of membranebound COX was carried out using methods modified from those of Van der Ouderaa et al. (26) . Third generation PA were homogenized on ice in 50 mM KH2PO4 buffer containing the following (mM): 250 mannitol, 5 disodium EDTA, 0.3 diethyldithiocarbamate, and 0.1 indomethacin, pH 7.8, using a Polytron blender (Brinkmann Instruments, Westbury, NY). The homogenate was centrifuged at 12,000 g at 4°C for 10 min, and the supernatant was centrifuged at 1 10,000 g at 4°C for 2 h. The pellet was resuspended in ice-cold 50 mM KH2PO4 buffer containing 0.1 mM diethyldithiocarbamate and 1% Tween-20 and was ultrasonically disrupted (Branson Ultrasonics, Chicago, IL). The protein content ofthe microsomal preparation was determined by the method of Bradford (27) using bovine serum albumin as the standard.
SDS-PAGE was performed with 7% acrylamide by the method of Laemmli et al. (28) , and the proteins were electrophoretically transferred to nitrocellulose filters overnight. The nitrocellulose filters were blocked for 1 h in buffer containing the following (mM): 100 NaCl, 20 NaH2PO4, and 80 Na2HPO4 (PBS, pH 7.5) with 1% Tween-20 and 5% dried milk and then incubated with 1:1,000 ovine COX antiserum (Cayman Chemical Co., Ann Arbor, MI) for 1 h at room temperature. This rabbit anti-sheep polyclonal antiserum recognizes both isoforms of COX (COX-I and COX-2) (29). COX-I is purportedly the constitutive isoform, and COX-2 is inducible and is thought to have a role in inflammatory processes (29, 30). After incubation with primary antiserum, the nitrocellulose filters were washed in PBS with 1% Tween-20 and incubated for 1 h with a 1:10,000 dilution of an anti-rabbit Ig antibody-horseradish peroxidase conjugate raised in donkey (Amersham Corp., Amersham, UK). The filters were washed in PBS with Tween-20 and the bands for COX were visualized by chemiluminescence (ECL Western Blotting Analysis System; Amersham) and quantitated by densitometry. Additional immunoblots were performed with antiserum specific for COX-2 (Oxford Biomedical Research, Inc., Oxford, MI). Purified COX-I and COX-2 were used as positive controls. Three independent experiments were performed using samples from separate groups of animals.
Northern analysis for COX mRNA. Total cellular RNA was obtained and purified from the lungs by a single extraction method with an acid guanidinium thiocyanate-phenol-chloroform mixture (31) . The total RNA was subjected to oligo-dT affinity chromatography to obtain poly-A(+) RNA (32) . The poly-A(+) RNA (5-15 gg) was size Developmental Regulation ofPulmonary Artery Prostacyclin Synthesis 2231 fractionated on 1.0% agarose formaldehyde gels and transferred to nylon membranes. The RNA was cross-linked to the membranes by ultraviolet irradiation. After prehybridization, the membranes were hybridized overnight at 420C in the presence ofa random-primed 32P-labeled COX-I cDNA probe (Cayman Chemical Co.). After hybridization, the blots were washed and autoradiography was performed. Northern analysis was also performed for the housekeeping gene malate dehydrogenase using a 0.5-kb random-primed 32P-labeled cDNA probe to verify equivalent RNA stability and loading between samples (33). Three independent experiments were performed using samples from separate groups of animals.
Statistical analysis. ANOVA with Neuman-Keuls post hoc testing was used to compare mean values between more than two groups.
Nonparametric ANOVA was used when indicated. Single comparisons between two groups were performed with paired and nonpaired Student's t tests. Significance was accepted at the 0.05 level of probability.
All results are expressed as mean±SEM.
Results
Basalprostaglandin synthesis. The ontogeny ofbasal PGI2 synthesis in PA and mesenteric artery is shown in Fig. 1 . PGI2 synthesis in PA increased fourfold from Fl to F2, an additional fourfold from F2 to NB1, and another twofold from NB1 to NB2, yielding a 32-fold increase from early third trimester to the late newborn period. In the mesenteric artery there was no difference in PGI2 synthesis in the four age groups.
The ontogeny ofPGE2 synthesis is depicted in Fig. 2 . In PA, PGE2 synthesis increased fourfold from Fl to F2, but it then fell from F2 to NB1 to levels comparable to F1. PA PGE2 synthesis was similar in NB l and NB2. A comparable developmental pattern was observed in the mesenteric artery.
The effects of endothelium removal on PGI2 synthesis in PA from F2, NB1, and NB2 lambs are shown in Fig. 3 . Removal of the endothelium resulted in a 70% decrease in PGI2 synthesis in F2, a 72% decrease in NB 1, and a 66% decrease in NB2. In the segments denuded of endothelium there was a fourfold increase in PGI2 synthesis between F2 and NB1 and another threefold increase between NB I and NB2, paralleling the developmental rises demonstrated in the intact segments.
Stimulated PGI2 synthesis. To investigate the mechanism underlying the developmental increase in PA PGI2 synthesis, segments from F2, NB 1, and NB2 were incubated in the presence of agents that cause stimulation of the synthetic pathway at various steps. In these experiments, basal synthesis rose 122% from F2 to NBl and 64% from NB1 to NB2 (Fig. 4) . Synthesis maximally stimulated by bradykinin (Fig. 4, top) increased 82% from F2 to NBl and 84% from NBl to NB2, paralleling the increases in basal synthesis. Synthesis maximally stimulated by A23187 (Fig. 4, middle) increased 89% from F2 to NBl and 54% from NBl to NB2, also in parallel with the developmental increases observed in basal synthesis. Arachidonic acid-stimulated synthesis (Fig. 4, bottom) maturational increases were also comparable to the changes noted in basal synthesis.
In a second series of experiments, concomitant determinations of basal and PGH2-stimulated PG12 synthesis were made. In these studies basal synthesis increased 4.2-fold from F2 to NB 1 and 1.9-fold from NB 1 to NB2 (Fig. 5 ) . In contrast to the findings for basal synthesis and for stimulation with bradykinin, A23187, or arachidonic acid (Fig. 4) , there were no differences between F2, NB 1, and NB2 in synthesis maximally stimulated by PGH2.
COX protein expression. Maturational changes in COX protein expression in PA from F2, NB1, and NB2 lambs are depicted in Fig. 6 . In the representative immunoblot shown, the antiserum used recognizes both COX-I and COX-2, which are of comparable size (70 kD) (29). COX protein abundance increased progressively from F2 to NBl to NB2. Quantitative densitometry from three independent experiments concurred with these observations, revealing that the abundance of COX F2 NBI NB2 Figure 6 
Discussion
In this study we have demonstrated that there is a 32-fold increase in PGI2 synthesis in ovine PA during the third trimester and the early postnatal period. In contrast, there is no change in PGI2 synthesis in comparably sized mesenteric arteries. In both the PA and mesenteric arteries, PGE2 synthesis rises during late gestation, but it then falls in the newborn period. These observations indicate that PGI2 synthesis in the PA is developmentally regulated in a manner that is unique to that vascular bed and also to that prostanoid.
The findings in the PA confirm our previous results in this species (22). The observed developmental increase in PA PGI2 synthesis is consistent with the findings of Omini et al. (34) , who reported that angiotensin-induced PGI2 synthesis in perfused rabbit lungs is greater in the newborn compared with the F2 NB1 NB2 Figure 5 . fetus. In addition, the late fetal increase in PA PGE2 synthesis is consistent with results in both bovine and ovine lung homogenates (14, 15) . Furthermore, studies in rabbit lung homogenates have shown that PGE2 synthesis from arachidonic acid increases during gestation to a maximum near term, and it then decreases during the early postnatal period ( 15 ) , closely mimicking the observed rise and fall in ovine PA PGE2 synthesis.
We have also determined whether the developmental increase in PA PGI2 synthesis occurs in the endothelium or in the VSM. Endothelium removal resulted in comparable deductions (66-72%) in PGI2 synthesis in PA from all age groups. Considering the relative masses of the endothelium and VSM, such a dramatic fall in synthesis after denudation indicates that the majority of PGI2 synthesis occurs in the endothelium of both fetal and newborn arteries. This extends our previous observations in ovine fetal pulmonary arteries (21) . Furthermore, because the developmental increase in PGI2 synthesis was observed in both the intact and denuded segments, it occurs in both the endothelium and the VSM.
In addition, we have identified the step in the synthetic cascade that is involved in the developmental regulation of PA PGI2 synthesis. First, we examined the effects of development on PGI2 synthesis maximally stimulated with bradykinin, which acts via receptor-mediated processes (24) . The maturational increase in PGI2 production seen in the absence ofexogenous stimulation (basal) was preserved in segments stimulated with bradykinin. These results indicate that the effect ofdevelopment is not due to changes in the production ofa local receptor agonist, and that it must be more distal in the synthetic pathway.
We next evaluated the stimulation of PGI2 synthesis by non-receptor-mediated activation of arachidonic acid mobilization using A23 187 (25) . The degree ofenhancement ofbasal PGI2 synthesis seen with maturation was mimicked in segments maximally stimulated with A23187, indicating that the effect ofdevelopment on PGI2 synthesis does not involve alterations in arachidonic acid mobilization. This conclusion is supported by the observation that segments incubated with excess arachidonic acid also exhibited increases in PGI2 production with development that were comparable to the changes in basal synthesis. As such, the effect of maturation on PGI2 synthesis must be at the level of COX or PGI2 synthetase.
The possible effects of development on the activities of these enzymes in the PA were differentiated by stimulating PGI2 synthesis with exogenous PGH2, the product ofCOX and the substrate for PGI2 synthetase (25) . PGI2 synthesis stimulated by PGH2 was similar in all age groups, indicating that the maturational increase in basal synthesis is not related to enhanced PGI2 synthetase activity, but to increased COX activity. These findings are in agreement with the observations of Printz and coworkers ( 13) that COX activity in ovine lung homogenates increases with development in the late fetus and newborn, whereas PGI2 synthetase activity does not. In addition, our results indicating that PA PGE2 synthesis declines in the newborn and the corroborating observations by Powell and Solomon ( 15) in rabbit lung suggest that there is a fall in PGH2-PGE2 isomerase activity postnatally.
The activity ofCOX is dependent not only on the provision of arachidonic acid as substrate, but also on the availability of molecular oxygen, hydroperoxides, and heme (26, 35, 36) . The abundance of the enzyme protein is also critical in many systems because COX undergoes self-catalyzed inactivation (36) , with a half-life < 10 min (37, 38) . In the present study, PGI2 synthesis was determined at high levels ofin vitro oxygenation, excluding the availability of molecular 02 as a factor; maturational changes in hydroperoxide and heme abundance were not evaluated. Immunoblot analyses revealed that there is a marked developmental increase in COX protein abundance in the ovine PA and that it is primarily the COX-1 isoform. COX-1 and COX-2 are both expressed in vascular cells (29), the former being purportedly constitutive in nature and the latter inducible and possibly involved in inflammatory processes (29, 30). Experiments were not performed to examine the inducibility of COX-2 during development. In the present study steady state levels of COX-I mRNA were also found to rise dramatically in the lung with maturation. Because the endothelium and VSM are the primary sources of PGI2 in the lung, it is most likely that the increases in COX-1 mRNA occur in those cell types. As such, it is concluded that COX-1 gene expression is developmentally regulated in PA, and that this may involve changes in transcription rate or mRNA stability.
There are important physiological ramifications ofthe findings in this study. The developmental increase in PA COX expression in the fetus may optimize the capacity for rapid PGI2-mediated pulmonary vasodilatation immediately at the time ofbirth in response to oxygenation, ventilation, and shear stress (39, 40) . The existence of the latter mechanism is supported by the observation of Abman and Accurso (41 ) that partial compression of the ductus arteriosus of the late gestation fetal lamb causes a rapid increase in pulmonary blood flow, which is attenuated by COX inhibition. It has also been demonstrated that lung PGI2 content increases after cesarean section delivery of late gestation lambs (42) . In addition, the continued maturational rise in COX expression in the newborn and the resulting increase in PGI2 synthesis may contribute to the normal fall in pulmonary vascular resistance, which also occurs more gradually in the early postnatal period (43) . Furthermore, because PGI2 attenuates VSM growth (10, 11) and the maturational increase in its synthesis parallels the decline in pulmonary arterial muscularity from fetal to postnatal life (16) , developmental changes in PGI2 synthesis may also play a role in normal maturational alterations in pulmonary vessel structure. However, caution may be warranted in the direct extrapolation of the present observations to in vivo processes because these studies were performed in vitro in conductance and not resistance vessels.
Our observations also have potential pathophysiological implications because diminished PGI2 synthesis has been associated with certain forms of pulmonary hypertension. Although lung PGI2 content is not decreased in an ovine model of perinatal pulmonary hypertension specifically induced by ductus compression for 9-12 d (42) , prolonged inhibition ofprostaglandin synthesis induces pulmonary hypertension and alterations in lung vessel morphology in adult sheep (8) . In addition, chronic hypoxic pulmonary hypertension in adult rats and the structural changes that accompany it are negated by the administration of agents that stimulate vascular PGI2 synthesis (9) . Furthermore, it has been demonstrated that PA PGI2 synthesis is attenuated in newborn calves with chronic hypoxic pulmonary hypertension (44). When these findings are considered along with the present results indicating that the normal maturational rise in PA PGI2 synthesis is related to increased COX expression, it is postulated that there may be conditions in which attenuated COX expression contributes to pulmonary hypertension in the newborn.
In summary, we have demonstrated that PGI2 synthesis in ovine PA increases markedly during late fetal and early newborn life. The increase in PGI2 is specific to the PA, it occurs in both the endothelium and VSM, and it is due to a rise in COX activity related to enhanced expression of the COX-I isoform. We conclude that there is a developmental increase in PA COX-1 gene expression, and that this may be critical to successful cardiopulmonary transition and function in the newborn.
